Deerfield Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.93M Sell
101,000
-625,000
-86% -$26.2M 0.06% 73
2026
Q1
$23.4M Hold
726,000
0.28% 57
2025
Q4
$30.6M Hold
726,000
0.39% 49
2025
Q3
$24.9M Buy
726,000
+101,000
+16% +$2.9M 0.38% 57
2025
Q2
$16.9M Buy
+625,000
New +$18.1M 0.31% 56
2024
Q4
Sell
-12,032
Closed -$410K 433
2024
Q3
$410K Buy
+12,032
New +$338K 0.01% 322
2024
Q2
Sell
-10,011
Closed -$222K 566
2024
Q1
$222K Buy
+10,011
New +$244K ﹤0.01% 315
2016
Q2
Sell
-165,097
Closed -$892K 118
2016
Q1
$892K Sell
165,097
-227,050
-58% -$1.34M 0.04% 96
2015
Q4
$2.82M Buy
392,147
+8,891
+2% +$59.9K 0.11% 94
2015
Q3
$1.8M Hold
383,256
0.07% 116
2015
Q2
$4.27M Buy
+383,256
New +$3.77M 0.14% 97

Other funds holding VCYT

Deerfield Management's VCYT Position: Q2 2026 in Review

Deerfield Management reduced its Veracyte (VCYT) stake by 86% in Q2 2026, selling an estimated $26.2M and leaving 101,000 shares worth $5.93M. The position accounts for 0.06% of the portfolio, ranked #73.

Deerfield Management first reported a position in VCYT in Q2 2015 and has held it in 11 quarters since. The position peaked at $30.6M in Q4 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Deerfield Management held 101,000 shares of Veracyte worth $5.93M as of Q2 2026.
  • Deerfield Management sold 625,000 Veracyte shares in Q2 2026, an estimated $26.2M.
  • Veracyte made up 0.06% of Deerfield Management's portfolio in Q2 2026, its #73 holding.
  • Deerfield Management first reported a position in Veracyte in Q2 2015 and has held it in 11 quarters since.
  • Deerfield Management's Veracyte position peaked at $30.6M in Q4 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.